Visitors and news

Cervical cancer is a significant health problem in Europe. WHO Member States have collectively resolved to end needless suffering from a cancer that is preventable, curable and could be eliminated within a generation by adopting the global strategy to accelerate the elimination of cervical cancer as a public health problem in November 2020. The objective of this webinar organized by the Associations of the European Cancer Leagues in collaboration with UICC, MEP, European Commission DG Santé and IARC is to inform a wide audience of health stakeholders about the global strategy and discuss Europe’s role in taking global commitments forward and signalling the importance of cervical health to European Member States, Associated countries and beyond. View the agenda and join the meeting

In this new article, published in the International Journal of Cancer, the IARC COVID-19 impact study group including scientists from IARC and representatives from 17 countries in charge of cancer screening programmes, conducted a study to assess the impact of the pandemic on cancer screening programmes in LMICs that have made significant efforts in the past few years to improve the organization of their screening programmes. Based on our best knowledge, our study is the first reporting on the impact of COVID-19 outbreak on cancer screening care continuum for a set of low- and middle-income countries spread across different continents and Human development index categories. The status of the cancer testing, diagnostic and treatment services, and challenges and the best practices adopted to face the crisis are described. Sharing such information will help LMICs to improve resilience of screening services. View the article

The COVID-19 pandemic, caused by the SARS-CoV-2 coronavirus, poses a clear and present danger to the health and well-being of populations. A new comment, published in Nature Cancer by Dr Ophira Ginsburg, Dr Partha Basu, Dr Sharon Kapambwe and Dr Karen Canfell, discuss its indirect impact on global cancer prevention and control efforts, particularly for cervical cancer. Authors suggest some comparisons between the COVID-19 pandemic and the human papillomavirus–induced cancer burden, as well as opportunities for translating pandemic-control strategies into effective cancer control. View the commentary

In the present review article published in Cancer Causes Control, the authors discussed the possible role of integrative medicine across the breast cancer care continuum with the concept of integrating complementary practices into mainstream health delivery. Authors have focused on breast cancer as a model cancer that is well amenable to prevention, early detection and stage appropriate treatment. However, their observations are pertinent for other common cancers, for which there are several opportunities for improving the continuum of care, especially in developing countries like India.View the article

This atlas is an online manual that describes the use of VIA as primary screening teest or as a test to triage HPV-positive women, and provides techniques or to determine eligibility for ablative treatment.
View the digital atlas and the atlas flyer

IARC Summer School 2021 applications are now open! Courses will be held fully online this year, offering a unique opportunity to learn and benefit from IARC’s expertise from anywhere in the world! Two modules will be offered this year: “Introduction to Cancer Epidemiology” and “Implementing Cancer Prevention and Early Detection”. Application deadline: 1 March.
Apply now.

Continuation of the CanScreen5 Train the Trainers African course, with participants from 17 African countries. The CanScreen5 Train the Trainers course aims to contribute to the creation of a dynamic global network of master trainers capable of training health care providers on cancer screening program monitoring, evaluation and quality improvement and also to contribute data to the CanScreen5 project. Today, Dr P. Basu, deputy head, Early Detection, Prevention and Infections (EPR) Branch, addressed a key not lecture about Cancer screening during and after the COVID-19 pandemic. Learn more about the CanScreen5 platform.

The burden of cancer is rising worldwide. The International Agency for Research on Cancer / World Health Organization (IARC) is focused on cancer research for cancer prevention and promoting international scientific collaborations. Soon, IARC will move to their new HQ, which is currently under construction in the Biodistrict in Gerland, Lyon, France. To continue their important work, they need to buy or receive equipment to outfit the new labs and offices. That’s why they have launched an in-kind contribution campaign and are open to donations, large and small, from individuals and institutions. 7 million lives could be saved from cancer in the next decade alone with the correct prevention strategies. IARC produces the evidence needed to support these strategies and prove that they work. Please support IARC’s research and their move to the new HQ. Supporting IARC is helping contribute to a world with less cancer, especially in low- and middle-income countries where cancer is increasing the most. Learn more about the Nouveau Centre and how to join the circle of IARC donors.

HRH Princess Ghida Talal, Chairperson of the King Hussein Cancer Foundation and Center, launched the King Hussein Cancer Research Award to honor Arab leaders in cancer research who have made outstanding achievements in the fields of prevention, early detection, diagnosis, treatment, and palliative care. Increased scientific research will lead us to a stronger future of confronting cancer in the Middle East region. We encourage you to visit the Award website.
View the website

Despite the ongoing pandemic, the NCI Center for Global Health (NCI/CGH) hosted a webinar at London Global Cancer Week in November 2020. “International Collaboration to Advance Global Cancer Research: The US National Cancer Institute Perspective” showcased NCI-funded research training and collaborations, along with lessons learned and recommendations for building international partnerships to advance global cancer research and control. Consult a summary of the interventions, including a presentation from Dr Partha Basu on building a team to implement affordable technology to treat cervical cancer in Zambia. View the website